SEC 13F Intelligence

Ingalls & Snyder LLC / CNQ

Ingalls & Snyder LLC’s Canadian Nat Res Ltd Med Ter Position

Does Ingalls & Snyder LLC own Canadian Nat Res Ltd Med Ter (CNQ)? Yes2.34M shares worth $114M (+4.03% of its 13F portfolio) as of Q1 2026, down from 2.40M shares the prior filed quarter.

Position Value
$114M
Q1 2026
Shares
2.34M
% of Portfolio
+4.03%
Quarters Held
29
currently held

Position History CNQ

Reported value by quarter
Q1 ’19: $61MQ1 ’19Q2 ’19: $53MQ3 ’19: $50MQ4 ’19: $59MQ1 ’20: $24MQ1 ’20Q2 ’20: $30MQ3 ’20: $28MQ4 ’20: $43MQ1 ’21: $58MQ1 ’21Q2 ’21: $68MQ3 ’21: $69MQ4 ’21: $77MQ1 ’22: $96MQ1 ’22Q2 ’22: $83MQ3 ’22: $72MQ4 ’22: $85MQ1 ’23: $90MQ1 ’23Q2 ’23: $91MQ3 ’23: $104MQ4 ’23: $101MQ1 ’24: $105MQ1 ’24Q2 ’24: $96MQ3 ’24: $90MQ4 ’24: $81MQ1 ’25: $79MQ1 ’25Q2 ’25: $82MQ3 ’25: $82MQ4 ’25: $81MQ1 ’26: $114MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.34M$114M+4.03%
Q4 20252.40M$81M+2.98%
Q3 20252.58M$82M+2.70%
Q2 20252.60M$82M+2.89%
Q1 20252.58M$79M+2.61%
Q4 20242.62M$81M+3.17%
Q3 20242.72M$90M+3.52%
Q2 20242.68M$96M+4.11%
Q1 20241.38M$105M+4.64%
Q4 20231.54M$101M+4.56%
Q3 20231.60M$104M+4.99%
Q2 20231.62M$91M+4.37%
Q1 20231.63M$90M+4.62%
Q4 20221.53M$85M+4.63%
Q3 20221.55M$72M+4.02%
Q2 20221.55M$83M+4.35%
Q1 20221.55M$96M+4.29%
Q4 20211.82M$77M+3.47%
Q3 20211.90M$69M+3.18%
Q2 20211.88M$68M+3.03%
Q1 20211.86M$58M+2.69%
Q4 20201.78M$43M+2.11%
Q3 20201.74M$28M+1.91%
Q2 20201.71M$30M+1.71%
Q1 20201.79M$24M+1.63%
Q4 20191.83M$59M+3.21%
Q3 20191.89M$50M+2.45%
Q2 20191.97M$53M+2.56%
Q1 20192.21M$61M+2.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ingalls & Snyder LLC’s full portfolio or all institutional holders of CNQ.